我国牵头组建国际标准化组织生物技术委员会类器官工作组

Core Insights - The establishment of the International Organization for Standardization (ISO) Biotechnology Committee's Organoid Working Group is a significant development in China's biotechnology standardization efforts [1] - Organoids, which are miniaturized tissue models derived from stem cells, have substantial value in biomedical fields, including precise disease diagnosis and personalized drug screening [1] - The conference outcomes mark a major breakthrough in the standardization of biotechnology in China and represent an important milestone for the standardized and high-quality development of the stem cell and organoid industry [1] Industry Developments - The conference was hosted by the China Stem Cell and Regenerative Medicine Collaborative Innovation Platform, with support from various institutions including the Beijing Stem Cell and Regenerative Medicine Research Institute and the Chinese Academy of Sciences [2] - The release of two international standards and five group standards by the Chinese Society for Cell Biology highlights the collaborative efforts in establishing a standard system that will enhance China's participation in international cooperation [1] - The introduction of these standards is expected to bridge the gap between research and clinical applications, improve new drug development efficiency, and reduce costs and risks for the industry [1]